John Francis Hoffman - 26 Jun 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Director
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
26 Jun 2025
Transactions value $
$0
Form type
4
Filing time
27 Jun 2025, 17:31:24 UTC
Previous filing
23 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hoffman John Francis Director C/O ATAI LIFE SCIENCES N.V., PROF. J.H. BAVINCKLAAN 7, AMSTERDAM, NETHERLANDS /s/ Ryan Barrett, Attorney-in-fact 27 Jun 2025 0002070006

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +206K $0.00 206K 26 Jun 2025 Common Shares 206K $2.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest as to 1/3rd of the underlying shares on June 26, 2026 and as to the remaining underlying shares in twenty-four (24) substantially equal monthly installments thereafter, such that the option will become fully vested on June 26, 2028.